Metronidazole Tablets BP 400 mg Manufacturer

Metronidazole Tablets BP 400 mg Manufacturer in India – Healthy Life Pharma Pvt. Ltd.

Metronidazole Tablets BP 400 mg Manufacturer product packaging

Metronidazole Tablets BP 400 mg | Manufacturer

Product image for Metronidazole Tablets BP 400 mg Manufacturer; contract manufacturing, oem & quality control.

Product Information

Generic NameMetronidazole
ManufacturerHealthy Life Pharma Pvt. Ltd.
HSN Code30049022
PharmacopoeiaBP
Product TypeTablet
CategoryAntiprotozoal drugs
SubcategoryAntiprotozoal drugs
Active IngredientMetronidazole
Strength400 mg
Dosage FormTablet
Pack Size10 x 10 Tablets / Box (Alu-Alu / Blister)
Route of AdministrationOral
Prescription RequiredYes
Therapeutic CategoryAntiprotozoal drugs

Medicine Details & Safety

Short DescriptionHealthy Life Pharma invites contract and third-party manufacturing enquiries for Metronidazole Tablets BP 400 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements.
Approved Uses / Indications1. Treatment of upper and lower respiratory tract infections (bronchitis, pneumonia, sinusitis, pharyngitis). 2. Treatment of skin and soft tissue infections, uncomplicated urinary tract infections, and gastrointestinal bacterial infections.
Full Description

Healthy Life Pharma invites contract and third-party manufacturing enquiries for Metronidazole Tablets BP 400 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements.

Product technical specifications

Generic nameMetronidazole
CompositionMetronidazole
Strength400 mg
CategoryAntiprotozoal drugs
PharmacopoeiaBP
Dosage formTablet

Product technical specifications

Generic nameAcarbose
CompositionAcarbose
Strength25 mg
CategoryAntidiabetic Drugs
PharmacopoeiaUSP / IP
Dosage formTablet

Manufacturing capabilities and infrastructure

For Metronidazole Tablets BP 400 mg, assess the approved formulation process, equipment suitability, batch scale and in-process controls for the Tablet presentation. Confirm environmental requirements and validated process before production.

Quality control and assurance

Request the approved finished-product specification for Metronidazole Tablets BP 400 mg, including applicable identity, assay, uniformity and performance tests for the Tablet presentation. Confirm analytical methods, acceptance criteria and batch release documentation, including COA availability.

Primary and secondary packaging

The catalogue pack for Metronidazole Tablets BP 400 mg is 10 x 10 Tablets / Box (Alu-Alu / Blister). Confirm primary packaging compatibility, stability evidence, artwork, batch coding and leaflet requirements against the approved specification.

Contract manufacturing and private label

Submit the target market, strength, pharmacopoeial specification, forecast volume and brand artwork. Agree feasibility, batch size, quality agreement, production schedule and release criteria before execution.
Dosage InstructionsAdminister orally at evenly spaced intervals around the clock. Swallow whole with water; complete the entire prescribed antimicrobial regimen even if symptoms resolve earlier, to prevent emergence of antimicrobial resistance.
Side EffectsCommon: Nausea, diarrhea, abdominal cramps, vomiting, dysgeusia (taste alteration). Uncommon: Headache, dizziness, candidiasis (oral or vaginal thrush), transient transaminase rise. Rare: Pseudomembranous colitis (C. difficile), severe cutaneous adverse reactions, anaphylaxis.
Warnings and PrecautionsAntimicrobial Resistance: Use strictly for culture-proven or strongly suspected bacterial infections. Clostridioides difficile Colitis: Discontinue immediately if severe, persistent watery diarrhea develops. Hypersensitivity Alert: Screen for past history of drug allergies before initiation.
Contraindications1. Documented hypersensitivity to Metronidazole or chemically related antibacterial classes.
2. Severe hepatic necrosis or jaundice associated with prior use.
3. Concurrent use with contraindicated QTc-prolonging or hepatotoxic substances.
Drug Interactions1. Antacids & Polyvalent Cations (Al, Mg, Fe, Ca): Significantly reduce oral bioavailability; separate dosing by 2 hours.
2. Oral Anticoagulants (Warfarin): May potentiate hypoprothrombinemic effect and elevate INR.
3. Live Vaccines: Antibacterial therapy may attenuate response to oral typhoid or BCG vaccine.

Frequently Asked Questions

QuestionAnswer
Can I request third-party manufacturing for Metronidazole Tablets BP 400 mg?Submit your brand, quantity and packaging requirements for manufacturing feasibility review.
Which pharmacopoeial standard applies for Metronidazole Tablets BP 400 mg?The source specification is BP; confirm the required standard before contracting.
What quality tests are applicable for Metronidazole Tablets BP 400 mg?Request the approved finished-product specification and batch testing plan.
Can packaging be customized for Metronidazole Tablets BP 400 mg?Submit artwork and pack requirements for technical and regulatory review.
How do I request a manufacturing quotation for Metronidazole Tablets BP 400 mg?Provide forecast volume, target market, strength and packaging requirements.

Product Hashtags

#Metronidazole#Manufacturer#PharmaB2B

Related Products

Latest Posts